InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Ra Capital Healthcare Fund Lp, Director,TenPercentOwner, is a corporate insider tracked by InsiderTape across 12 companies. The public record shows 18 open-market SEC Form 4 transactions: 16 purchases worth $210.1M and 2 sales worth $42.3M, reported from Mar 14, 22 to Feb 9, 26. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 9, 26 | SGPSpyGlass Pharma, Inc. | BUY | 3.44M | $16.00 | $55.1M |
| Jan 5, 26 | CLYMClimb Bio, Inc. | BUY | 7.1K | $3.50 | $25K |
| Dec 8, 25 | FULCFulcrum Therapeutics, Inc. | SELL | 2.71M | $14.98 | $38.6M |
| Sep 26, 25 | PEPGPepGen Inc. | BUY | 9.38M | $3.20 | $30.0M |
| Jun 9, 25 | TYRATyra Biosciences, Inc. | BUY | 186.8K | $10.19 | $1.9M |
| Mar 7, 25 | JANXJanux Therapeutics, Inc. | BUY | 110.2K | $31.02 | $3.4M |
| Mar 6, 25 | JANXJanux Therapeutics, Inc. | BUY | 372.1K | $30.78 | $11.5M |
| Mar 5, 25 | JANXJanux Therapeutics, Inc. | BUY | 304.3K | $31.30 | $9.3M |
| Nov 8, 24 | TYRATyra Biosciences, Inc. | BUY | 1.22M | $16.25 | $19.8M |
| Aug 9, 24 | ANTXAN2 Therapeutics, Inc. | SELL | 3.41M | $1.08 | $3.7M |
| Sep 21, 23 | SPRYARS Pharmaceuticals, Inc. | BUY | 2.51M | $3.83 | $7.5M |
| Jan 4, 23 | FULCFulcrum Therapeutics, Inc. | BUY | 122.3K | $7.80 | $860K |
| Nov 17, 22 | ACRVAcrivon Therapeutics, Inc. | BUY | 3.39M | $12.50 | $42.4M |
| Jun 16, 22 | WVEWave Life Sciences Ltd. | BUY | 9.48M | $2.15 | $20.4M |
| Mar 29, 22 | ICVXIcosavax, Inc. | BUY | 8.9K | $4.75 | $42K |
| Mar 28, 22 | ICVXIcosavax, Inc. | BUY | 175.3K | $4.53 | $794K |
| Mar 15, 22 | CTKBCytek Biosciences, Inc. | BUY | 241.7K | $12.27 | $3.0M |
| Mar 14, 22 | CTKBCytek Biosciences, Inc. | BUY | 342.1K | $12.35 | $4.2M |